Through a strategic biomarker collaboration,  Targos Molecular Pathology GmbH will provide know-how, services, and quality standards to support WuXi’s bioanalytical work for pharmaceutical customers.  The collaboration will focus on the validation and analysis of clinical tissue biomarkers in cancer.  Targos will also provide its internationally known training and education to support pathologists and histotechnologists in generating accurate, objective and reproducible diagnostic results.

Adding these new molecular pathology testing services from Targos ensures that WuXi is offering our customers a comprehensive platform of services in soluble cell and tissue biomarkers.


Related links:

See official press release here.
WuXi and Pacific Biomarkers Announce Collaboration